Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
15.48
+0.07 (0.45%)
Apr 28, 2025, 10:31 AM EDT - Market open

Neurogene Market Cap

Neurogene has a market cap or net worth of $220.78 million as of April 28, 2025. Its market cap has decreased by -55.65% in one year.

Market Cap
220.78M
Enterprise Value
-80.20M
1-Year Change
-55.65%
Ranking
Category
Stock Price
$15.48

Market Cap Chart

Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $220.78M, an increase of 93.49%. That is a compound annual growth rate of 6.10%.

History

DateMarket Cap% Change
Apr 25, 2025230.10M-32.24%
Dec 31, 2024339.60M646.37%
Dec 29, 202345.50M109.68%
Dec 30, 202221.70M-89.39%
Dec 31, 2021204.50M-65.38%
Dec 31, 2020590.70M25.07%
Dec 31, 2019472.30M829.72%
Dec 31, 201850.80M-81.59%
Dec 29, 2017275.90M-28.65%
Dec 30, 2016386.70M80.03%
Dec 31, 2015214.80M167.83%
Dec 31, 201480.20M-29.71%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 794.31B
UnitedHealth Group 381.06B
Johnson & Johnson 371.93B
AbbVie 329.14B
Novo Nordisk 272.76B
Abbott Laboratories 223.47B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings